Photo from Fola May/X
Mar 19, 2024, 20:30
Fola May: New Guardant Health blood-based colorectal cancer screening test
Fola May, Associate Director of UCLA Specialty Training and Advanced Research Program, posted on X/Twitter:
”New Guardant Health blood-based colorectal cancer screening test:
- 83% sensitivity for CRC (good)
- 13% sensitivity for precancerous polyps (not good).
Does this signal switch from CRC prevention to early detection? Read further.”
Source: Fola May/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 1, 2024, 19:12
Nov 1, 2024, 17:46
Nov 1, 2024, 17:41
Nov 1, 2024, 17:27